196 related articles for article (PubMed ID: 2419946)
1. [Hepatitis B and primary cancer of the liver in intertropical Africa].
Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
3. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
[TBL] [Abstract][Full Text] [Related]
4. The relation of infection with the hepatitis B agent to primary hepatic carcinoma.
Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
Am J Pathol; 1975 Dec; 81(3):669-82. PubMed ID: 174434
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
6. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
[TBL] [Abstract][Full Text] [Related]
7. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in the incidence of postnecrotic cirrhosis in Israel: correlation with hepatitis B virus serological markers.
Enat R; Ben-Porath E; Joffe B; Baruch J; Lichtig C
Am J Gastroenterol; 1983 Oct; 78(10):656-60. PubMed ID: 6624742
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer.
Maupas P; Coursaget P; Goudeau A; Drucker J; Sankale M; Linhard J; Diebolt G
Ann Microbiol (Paris); 1977; 128(2):245-53. PubMed ID: 71006
[TBL] [Abstract][Full Text] [Related]
10. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
12. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
Madalinski K; Burczynska B; Heermann KH; Uy A; Gerlich WH
Clin Exp Immunol; 1991 Jun; 84(3):493-500. PubMed ID: 2044231
[TBL] [Abstract][Full Text] [Related]
13. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
14. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
[TBL] [Abstract][Full Text] [Related]
15. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
Stránský J; Vodák M; Zichová M
Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
[TBL] [Abstract][Full Text] [Related]
19. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
20. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
